Cargando…

Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors?

The cannabinoid type-2 G protein-coupled (CB(2)) receptor is an emerging therapeutic target for pain management and immune system modulation. In a mouse model of Alzheimer’s disease (AD) the orally administered natural product 4′-O-methylhonokiol (MH) has been shown to prevent amyloidogenesis and pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gertsch, Jürg, Anavi-Goffer, Sharon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419612/ https://www.ncbi.nlm.nih.gov/pubmed/22716035 http://dx.doi.org/10.1186/1742-2094-9-135

Ejemplares similares

Motor-like Tics are Mediated by CB(2) Cannabinoid Receptor-dependent and Independent Mechanisms Associated with Age and Sex
por: Gorberg, Victoria, et al.
Publicado: (2022)

4′-O-methylhonokiol increases levels of 2-arachidonoyl glycerol in mouse brain via selective inhibition of its COX-2-mediated oxygenation
por: Chicca, Andrea, et al.
Publicado: (2015)

Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma
por: Gruber, Thomas, et al.
Publicado: (2021)

4-O-Methylhonokiol Influences Normal Cardiovascular Development in Medaka Embryo
por: Singha, Santu K., et al.
Publicado: (2019)

Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models
por: Lee, Young-Jung, et al.
Publicado: (2012)

Detection of Impending Aggressive Outbursts in Patients with Psychiatric Disorders: Violence Clues from Dogs
por: Bakeman, Uriel, et al.
Publicado: (2019)

Cannabinoids and COVID-19
por: El Biali, Myriam, et al.
Publicado: (2020)

Cannabinoid crystal polymorphism
por: Filer, Crist N.
Publicado: (2022)

Filming the glial dreams: real-time imaging of cannabinoid receptor trafficking in astrocytes
por: Verkhratsky, Alexei
Publicado: (2009)

Cannabinoid receptor-2 attenuates neuroinflammation by promoting autophagy-mediated degradation of the NLRP3 inflammasome post spinal cord injury
por: Jiang, Fan, et al.
Publicado: (2022)

Alleviation of Kainic Acid-Induced Brain Barrier Dysfunction by 4-O-Methylhonokiol in In Vitro and In Vivo Models
por: Han, Jin-Yi, et al.
Publicado: (2015)

A role for cyclooxygenase-1 in β-amyloid-induced neuroinflammation
por: Candelario-Jalil, Eduardo
Publicado: (2009)

Neurogenetic and Epigenetic Aspects of Cannabinoids
por: Dennen, Catherine A., et al.
Publicado: (2022)

Cannabinoids and Innate Immunity: Taking a Toll on Neuroinflammation
por: Downer, Eric J.
Publicado: (2011)

2-O-Methylhonokiol Suppresses HCV Replication via TRAF6-Mediated NF-kB Activation
por: Jeong, Suyun, et al.
Publicado: (2021)

Cannabinoid receptor 2 evolutionary gene loss makes parrots more susceptible to neuroinflammation
por: Divín, Daniel, et al.
Publicado: (2022)

The New 4-O-Methylhonokiol Analog GS12021 Inhibits Inflammation and Macrophage Chemotaxis: Role of AMP-Activated Protein Kinase α Activation
por: Kim, Sora, et al.
Publicado: (2015)

Amelioration of Cognitive Dysfunction in APP/PS1 Double Transgenic Mice by Long-Term Treatment of 4-O-Methylhonokiol
por: Jung, Yu-Yeon, et al.
Publicado: (2014)

Sensitive determination of 4-O-methylhonokiol in rabbit plasma by high performance liquid chromatography and application to its pharmacokinetic investigation
por: Li, Ming-Yue, et al.
Publicado: (2011)

PPARγ, neuroinflammation, and disease
por: Mrak, Robert E, et al.
Publicado: (2004)

High hopes for cannabinoid agonists in the treatment of rheumatic diseases
por: Staunton, Caroline A, et al.
Publicado: (2014)

Is there an added value in more real‐world cannabinoids studies?
por: Eisenberg, Elon
Publicado: (2022)

Protective effect of the ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on scopolamine-induced memory impairment and the inhibition of acetylcholinesterase activity
por: Lee, Yong Kyung, et al.
Publicado: (2009)

β-Caryophyllene Inhibits Oxaliplatin-Induced Peripheral Neuropathy in Mice: Role of Cannabinoid Type 2 Receptors, Oxidative Stress and Neuroinflammation
por: Agnes, Jonathan Paulo, et al.
Publicado: (2023)

Linking neuroinflammation to motor neuron degeneration in ALS: The critical role of CXCL13/CXCR5
por: ARNOUX, Alizée, et al.
Publicado: (2020)

In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid
por: Gugliandolo, Agnese, et al.
Publicado: (2018)

The Magnolia Bioactive Constituent 4-O-Methylhonokiol Protects against High-Fat Diet-Induced Obesity and Systemic Insulin Resistance in Mice
por: Zhang, Zhiguo, et al.
Publicado: (2014)

Effects of Intermittent Alcohol Exposure on Emotion and Cognition: A Potential Role for the Endogenous Cannabinoid System and Neuroinflammation
por: Sanchez-Marin, Laura, et al.
Publicado: (2017)

Editorial: Cannabinoids in neuroinflammation, neurodegeneration and pain: Focus on non-neuronal cells
por: Vecchiarelli, Haley A., et al.
Publicado: (2022)

Do N-arachidonyl-glycine (NA-glycine) and 2-arachidonoyl glycerol (2-AG) share mode of action and the binding site on the β(2) subunit of GABA(A) receptors?
por: Baur, Roland, et al.
Publicado: (2013)

Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention?
por: Marchalant, Yannick, et al.
Publicado: (2012)

4‐O‐methylhonokiol protects against diabetic cardiomyopathy in type 2 diabetic mice by activation of AMPK‐mediated cardiac lipid metabolism improvement
por: Zheng, Zongyu, et al.
Publicado: (2019)

“The Cannabinoid Receptors”
por: Reznicek, Gottfried
Publicado: (2010)

A cannabis oracle? Delphi method not a substitute for randomized controlled trials of cannabinoids as therapeutics
por: Hill, Kevin P., et al.
Publicado: (2021)

Cannabinoids and Cannabinoid Receptors: The Story so Far
por: Shahbazi, Fred, et al.
Publicado: (2020)

Cannabinoid Receptor 1 Agonist ACEA and Cannabinoid Receptor 2 Agonist GW833972A Attenuates Cell-Mediated Immunity by Different Biological Mechanisms
por: Takheaw, Nuchjira, et al.
Publicado: (2023)

Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study
por: Yamagishi, Satoru, et al.
Publicado: (2019)

Cannabinoid Modulation of Memory Consolidation in Rats: Beyond the Role of Cannabinoid Receptor Subtype 1
por: Ratano, Patrizia, et al.
Publicado: (2017)

Uncovering the psychoactivity of a cannabinoid from liverworts associated with a legal high
por: Chicca, A., et al.
Publicado: (2018)

Functional role of cannabinoid receptors in urinary bladder
por: Tyagi, Pradeep, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_7c3i201vqu694kfh195pdb3rfu